Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance

Merck (NYSE: MRK) reported Q4 EPS of $1.04, $0.01 better than the analyst estimate of $1.03. Revenue for the quarter came in at $11 billion versus the consensus estimate of $10.94 billion.

GUIDANCE:

Merck sees FY2019 EPS of $4.57-$4.72, versus the consensus of $4.69. Merck sees FY2019 revenue of $43.2-44.7 billion, versus the consensus of $44.54 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Titan Machinery (TITN) Misses Q2 EPS by 5c ; Offers Guidance